Page 122 - 79_02

Estandarización
de
un
modelo
murino…

22.
WHO,
Guidelines
for
the
treatment
of
P.
falciparum
malaria
in
WHO
Library
cataloguing-­-in-­-
Publication
Data,
Programme,
G.
M.,
Ed.,
World
Health
Organization
Switzerland
(2010).

23.
Dondorp,
A.,
Pathophysiology,
clinical
presentation
and
treatment
of
Cerebral
Malaria,

Neurology
Asia,
10,
67
(2005).

24.
Reis,
P.,
Comim,
C.,
Hermani,
F.,
Silva,
T.,
Barichello,
T.,
Portella,
A.,
Gomes,
F.,
Sab,
I.,

Frutuoso,
V.,
Oliveira,
M.,
Bozza,
P.,
Pizzol,
F.,
Zimmerman,
G.,
Quevedo,
J.
and
Neto,
H.,

Cognitive
Dysfunction
is
Sustained
after
Rescue
Therapy
in
Experimental
cerebral
Malaria,

and
is
Reduced
by
Additive
Antioxidant
Therapy.,
PLOS
pathogens
6,
1
(2010).

25.
Lou,
J.,
Lucas,
R.
and
Grau,
G.,
Pathogenesis
of
Cerebral
Malaria:
Recent
Experimental
Data

and
Possible
Applications
for
Humans,
Clinical
Microbiology
Reviews,
14,
810
(2001).

26.
De
Souza,
B.,
Hafalla,
J.,
Riley,
E.,
Couper,
K.,
Cerebral
Malaria:
why
experimental
murine

models
are
required
to
understand
the
pathogenesis
of
disease.,
Parasitology,
137,
755

(2009).

27.
Clemmer
L.,
M.
Y.,
Zanini
G.,
Frangos
A.,
Carvalho
L.
,
Artemether
and
artesunate
show
the

highest
efficacies
in
rescuing
mice
with
late-­-stage
cerebral
malaria
and
rapidly
decrease

leukocyte
accumulation
in
the
brain.,
Antimicrobial
Agents
and
Chemotherapy.,
55,
1383

(2011).

28.
Bienvenu
A.,
F.
J.,
Kaiser
K.,
Latour
C.,
Picot
S.,
Artesunate
-­-
Erythropoietin
combination
for

murine
cerebral
malaria
treatment.,
Acta
Tropica,
106,
104
(2008).

29.
Carvalho,
L.,
Murine
cerebral
malaria:
how
far
from
human
cerebral
malaria?
,
TRENDS
in

Parasitology,
26,
271
(2010).

30.
White,
N.,
Turner,
G.,
Medana,
I.,
Dondorp,
and
A
Day,
N.
,
The
murine
cerebral
malaria

phenomenon,
TRENDS
in
Parasitology,
26
(2009).

31.
Kicska,
G.
A.,
T.
Li-­-Min,
V.
L.
Shramm,
and
K.
Kim.,
Effect
of
dietary
p-­-aminobenzoic
acid
on

murine
Plamodium
yoelii
infection.
,
The
Journal
of
Infectious
Diseases,
188,
4680
(2003).

32.
Calderon,
J.,
Bolaños,
R.,
Carrillo,
J.,
Escamilla,
C.,
Salazar,
S.,
Moreno,
G.
and
Rivera,
G.,

Behavioral
analysis
of
the
Reserpine
induced
motor
changes
in
a
Parkinsonian
mouse

model.
,
Neuropsicología,
Neuropsiquiatría
y
Neurociencias.,
11,
49
(2011).

33.
Tadaiesky
M.,
A.
R.,
Vital
M.
,
Different
effects
of
7-­-nitroindazole
in
reserpine-­-
induced

hypolocomotion
in
two
strains
of
mice.
,
European
Journal
of
Pharmacology,
535,
199

(2006).

34.
Lambertsen,
C.
J.
B.,
PL.
Drabkin,
DL,
Schimidt,
C.,
Relationship
of
oxygen
tension
to

hemoglobin
oxygen
saturation
in
the
arterial
blood
of
normal
men,
Journal
Applied

Physiology,
1952,
873
(1952).

35.
Kozler,
P.
a.
P.,
J.,
Altered
Blood-­-Brain
Barried
Permeability
and
Its
Effect
on
the

Distribution
of
Evans
Blue
and
Sodium
Fluoresce
in
the
Rat
Brain
Applied
by
Intracarotid

Injection
Physiological
Research
52,
607
(2003).

36.
Van
der
Heyde,
H.
N.,
J.
Combes,
V.
Gramaglia,
I.
Grau,
GE.,
A
unified
hypothesis
for
the

genesis
of
cerebral
malaria:
sequestration,
inflammation
and
hemostasis
leading
to

microcirculatory
dysfunction.
,
TRENDS
in
Parasitology,
22,
503
(2006).

37.
Pongponratin,
E.,
Turner,
G.,
Day,
N.,
Phu,
N.,
Simpson,
J.,
Stepniewska,
K.,
Mai,
N.,
Vejakul,

P.,
Looreesuwan,
S.,
Hien,
T.,
Ferguson,
D.
and
White,
N.
,
An
Ultrastructural
Study
of
the

Brain
in
Fatal
Plasmodium
Falciparum
Malaria,
The
American
Society
of
Tropical
Medicine

and
Hygiene,
69,
345
(2003).

38.
Combes,
V.,
De
Souza,
B.,
Rénia,
L.,
Hunt,
N.
and
Grau,
G.
,
Cerebral
Malaria:
Which
parasite?

which
model?
,
Progress
in
Neurobiology,
91,
140
(2006).

39.
AQUAMAT,
G.,
Artesunate
versus
Quinine
in
the
treatment
of
severe
falciparum
malaria
in

African
children
(AQUAMAT):
an
open-­-label,
randomized
trial.
,
The
Lancet,
376,
1647

(2010).

291